Drug-induced lupus erythematosus

Archives of Dermatological Research

Volumn 301, Issue 1, 2009, Pages 99-105

  Vedove, Camilla Dalle ^a   Del Giglio, Micol ^a   Schena, Donatella ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Anti histone antibodies; Anti TNF induced lupus; Antinuclear antibodies (ANA); Drug reactions; Drug induced lupus erythematosus; Subacute cutaneous drug induced lupus (SCLE)

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTINUCLEAR ANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOUBLE STRANDED DNA; EFALIZUMAB; ETANERCEPT; FLUOROURACIL; GRISEOFULVIN; HISTONE ANTIBODY; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERFERON; ISONIAZID; LANSOPRAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROCAINAMIDE; TAMOXIFEN; TERBINAFINE; THIAZIDE DIURETIC AGENT; TICLOPIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG;

AUTOIMMUNITY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE EXACERBATION; HUMAN; INCIDENCE; KIDNEY DISEASE; LABORATORY TEST; LUPUS LIKE SYNDROME; PRIORITY JOURNAL; RARE DISEASE; REVIEW; RISK ASSESSMENT; SEROLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIBODIES; ANTIFUNGAL AGENTS; ANTIHYPERTENSIVE AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS; CALCIUM CHANNEL BLOCKERS; EXANTHEMA; HUMANS; HYDRALAZINE; INTERFERONS; ISONIAZID; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NAPHTHALENES; PROCAINAMIDE; SEROSITIS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149173373     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0895-5     Document Type: Review

References (41)

1. Y Allanore J Sellam F Batteux C Job Deslandre B Weill A Kahan 2004 Induction of autoantibody in refractory rheumatoid arthritis patients treated by infliximab Clin Exp Rheumatol 22 756 758
2. D Antonov J Kazandjieva D Etugov D Gospodinov N Tsankov 2004 Drug-induced lupus erythematosus Clin Dermatol 22 157 166 10.1016/j.clindermatol.2003.12.023
3. F Atzeni P Sarzi-Puttini D Dell'Acqua S De Portu G Cecchini C Cruini 2006 Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study Arthritis Res Ther 8 R3 10.1186/ar1851
4. AT Borchers CL Keen ME Gershwin 2007 Drug-induced lupus Ann N Y Acad Sci 1108 166 182 10.1196/annals.1422.019
5. FA Borg DA Isenberg 2007 Syndromes and complications of interferon therapy Curr Opin Rheumatol 19 61 66 10.1097/BOR.0b013e328010c547
6. P Caramaschi D Biasi M Colombatti S Pieropan N Martinelli A Carletto 2006 Anti-TNFα therapy in rheumatoid arthritis and autoimmunity Rheumatol Int 26 209 214 10.1007/s00296-004-0542-1
7. Costa MF, Said NR, Zimmermann B (2007) Drug-induced lupus due to anti-tumor necrosis factor α agents. Semin Arthritis Rheum. Epub ahead of print
8. N Danchenko JA Satia MS Anthony 2006 Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden Lupus 15 308 318 10.1191/0961203306lu2305xx
9. F D'Auria P Rovere-Querini M Giazzon P Ajello E Baldissera A Manfredi 2004 Accumulation of plasma nucleosomes upon treatment with anti-tumor necrosis factor-alpha antibodies J Intern Med 255 409 418 10.1111/j.1365-2796.2003.01298. x
10. M De Bant J Sibilia X Le Loet S Prouzeau B Fautrel C Marcelli E Boucquillard JL Siame X Mariette Club Rhumatismes et Inflammation 2005 Systemic lupus erythematosus induced by anti-tumor necrosis factor alpha therapy: a French national survey Arthritis Res Ther 7 R545 R551 10.1186/ar1715
11. L De Rycke D Baeten E Kruithof F Van den Bosch EM Veys F De Keyser 2005 Infliximab, but not etanercept, induces IgM anti-dsDNA antibodies as main antinuclear reactivity: biological and clinical implications in autoimmune arthritis Arthritis Rheum 52 2192 2201 10.1002/art.21190
12. SB Desai DE Furst 2006 Problems encountered during anti-tumor necrosis factor therapy Best Pract Res Clin Rheumatol 20 757 790 10.1016/j.berh.2006.06. 002
13. C Eriksson S Engstrand KG Sundqvist S Rantapaa-Dahlqvist 2005 Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha Ann Rheum Dis 64 403 407 10.1136/ard.2004.024182
14. F Fantuzzi M Del Giglio P Gisondi G Girolomoni 2008 Targeting TNF-α in psoriasis Exp Opin Ther Targets 12 1085 1096
15. G Ferraccioli F Mecchia E Di Poi M Fabris 2002 Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections Ann Rheum Dis 61 358 361 10.1136/ard.61.4.358
16. C Ferraro-Peyret F Coury JG Tebib J Bienvenu N Fabien 2004 Infliximab therapy in rheumatoid arthritis and ankylosing apondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study Arthritis Res Ther 6 R535 R543 10.1186/ar1440
17. P Gisondi G Girolomoni 2007 Biologic therapies in psoriasis: a new therapeutic approach Autoimmun Rev 6 515 519 10.1016/j.autrev.2006.12.002
18. E Gubinelli B Cocuroccia G Girolomoni 2003 Subacute cutaneous lupus erythematosus induced by nifedipine J Cutan Med Surg 7 243 246 10.1007/s10227-002-0122-5
19. SB Hanauer BG Feagan GR Lichtenstein LF Mayer S Schreiber JF Colombel D Rachmilewitz DC Wolf A Olson W Bao P Rutgeerts ACCENT I Study Group 2002 Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial Lancet 359 1541 1549 10.1016/S0140-6736(02)08512-4
20. ND Hopkinson M Doherty RJ Powell 1993 The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK 1989-1990 Br J Rheumatol 32 110 115 10.1093/rheumatology/32.2.110
21. S Jimenez R Cervera J Font M Ingelmo 2003 The epidemiology of systemic lupus erythematosus Clin Rev Allergy Immunol 25 3 12 10.1385/CRIAI:25:1:3
22. AE Johnson C Gordon RG Palmer PA Bacon 1995 The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth Arthritis Rheum 38 551 558 10.1002/art.1780380415
23. L Klareskog J Wajdula P Yeh 2005 Low autoantibody and anti-etanercept antibody formation and lack of impact on clinical outcomes after five years of treatment with etanercept in patients with rheumatoid arthritis Arthritis Rheum 52 Supplement S543 abstract 881
24. P Lopez Gutierrez C Mozo A Suarez 2003 Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features Lupus 12 860 865 10.1191/0961203303lu469xx
25. DJ Margolis O Hoffstad W Bilker 2007 Association or lack association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus Br J Dermatol 157 540 546 10.1111/j.1365-2133.2007.08056.x
26. A Mor CO Bingham L Barisoni E Lydon HM Belmont 2005 Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept J Rheumatol 32 740 743
27. Mor A, Pillinger MH, Wortmann RL, Mitnick HJ (2007) Drug-induced arthritic and connective tissue disorders. Sem Arthritis Rheum. Epub ahead of print
28. B Noel 2007 Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review J Eur Acad Dermatol Venereol 21 17 24 10.1111/j.1468-3083.2006.01838.x
29. Peroni A, Zini A, Braga V, Colato C, Adami S, Girolomoni G (2008) Drug-induced morphea: report of a case induced by balicatib and review of the literature. J Am Acad Dermatol. Epub ahead of print
30. N Poulalhon E Begon C Lebbé F Lioté M Lahfa D Bengoufa 2007 A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity Br J Dermatol 156 329 336 10.1111/j.1365-2133.2006.07639.x
31. A Rahaman DA Isenberg 2008 Systemic lupus erythematosus N Engl J Med 358 929 939 10.1056/NEJMra071297
32. M Ramos-Casals P Brito-Zeron S Munoz N Soria D Galiana L Bertolaccini 2007 Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases Medicine (Baltimore) 86 242 251 10.1097/MD.0b013e3181441a68
33. RL Rubin 2005 Drug-induced lupus Toxicology 209 135 147 10.1016/j.tox.2004.12.025
34. J Sellam Y Allanore F Batteux CJ Deslandre B Weill A Kahan 2005 Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and etanercept Joint Bone Spine 72 48 52 10.1016/j.jbspin.2004. 03.003
35. EC Somers SL Thomas L Smeeth WM Schoonen AJ Hall 2007 Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999 Arthritis Rheum 57 612 618 10.1002/art.22683
36. MB Stokes K Foster GS Markowitz F Ebrahimi W Hines D Kaufmen 2005 Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis Nephrol Dial Transplant 20 1400 1406 10.1093/ndt/gfh832
37. MC Sturkenboom CR Meier H Jick B Stricker 1999 Minocycline and lupuslike syndrome in acne patients Arch Intern Med 159 493 497 10.1001/archinte.159.5.493
38. Uetrecht J (2005) Drug-induced lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin, pp 117-132
39. AVAM van Rijthoven JWJ Bijlsma M Canninga- Van Dijk RHWM Derksen JAG van Roon 2006 Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level Rheumatology 45 1317 1319 10.1093/rheumatology/kel227
40. S Vasoo 2006 Drug-induced lupus: an update Lupus 15 757 761 10.1177/0961203306070000
41. CS Via A Shustov V Rus T Lang P Nguyen FD Finkelman 2001 In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL J Immunol 167 6821 6826